ClarityCare raises $16.5M to put an approve-only AI agent inside health plans

ClarityCare, a San Francisco company building AI for the payer side of prior authorisation, has closed a $16.5M Series A. The round was announced on 26 October, was oversubscribed and was led by Headline, taking total funding to nearly $20M. MedCity News puts the total at $19.8M.

Who came in

Arthur Ventures and FJ Labs joined as new investors. Maverick, firstminute, Top Harvest Capital and Transpose Platform, all existing backers, followed on. The company says the money will go on growing the team, building new products and expanding in the government sector, and it is hiring across engineering, clinical and sales roles.

Get Digital Health every TuesdayThree-minute read. Free. One-click unsubscribe.

What Electra does

Most prior auth automation has been built for providers trying to get requests out of the door. ClarityCare works the other end of the queue. Its agent, Electra, sits inside a health plan's utilisation management workflow and checks each incoming request against clinical guidelines and the member's benefits, logging how it reached every recommendation.

The key constraint is deliberate: Electra can approve a request or pass it up the chain, but it does not deny. Anything it cannot approve goes to a human reviewer. The latest version also handles the unglamorous plumbing that still dominates utilisation management: it works in fax inboxes, opens cases in UM systems, and prints letters and sends outbound faxes to close authorisations off.

"We're an AI services company, and we're here to solve the unsexiest problems in the system: the ones most patients never see, and never should." Hermine Tranie, Co-Founder and CEO, ClarityCare

The numbers

According to MedCity News, ClarityCare has seven customers, a mix of health plans, third-party administrators, medical management companies and government health services organisations supporting Medicaid and Medicare. The company told MedCity that one customer's prior auth waits fell from 12 days to two, and that its workflows touch care for around 6 million people. Both figures are company-reported.

Why now

The timing is driven by CMS rules. MedCity notes that payers face decision timeframes of 72 hours for expedited requests and seven days for standard ones, with a 1 January 2027 deadline for the rule's requirements. Tranie told MedCity that "Medicaid and Medicare Advantage plans face the most pressure from the new CMS rules", which explains the push into government work.

The bigger picture

The approve-only design matters because AI denials are under heavy scrutiny. Last week we covered a CMS official conceding that parts of the WISeR Medicare prior auth pilot were not working. A product that only speeds up approvals, and keeps clinicians on every no, is an easier sell to a plan's compliance team and an easier story to tell regulators. Expect more payer-side vendors to adopt the same line.

What it means for hiring

Selling into health plans is a different motion from selling to providers. We'd expect ClarityCare and its peers to look for sellers with payer and TPA relationships, particularly in Medicaid and Medicare Advantage.
Government-sector expansion usually means hiring people who know public-sector procurement and Medicaid managed care, a small and well-contested talent pool.
Clinical hires matter as much as engineers here: a human-in-the-loop product needs credible clinical reviewers and UM specialists to deploy and defend it.

Share Ask Issy about this →